These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 10992360

  • 1. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
    Chen GL, Bagley DH.
    J Urol; 2000 Oct; 164(4):1173-6. PubMed ID: 10992360
    [Abstract] [Full Text] [Related]

  • 2. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.
    Boorjian S, Ng C, Munver R, Palese MA, Vaughan ED, Sosa RE, Del Pizzo JJ, Scherr DS.
    Urology; 2005 Aug; 66(2):283-7. PubMed ID: 16098357
    [Abstract] [Full Text] [Related]

  • 3. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma.
    Keeley FX, Bibbo M, Bagley DH.
    J Urol; 1997 May; 157(5):1560-5. PubMed ID: 9112476
    [Abstract] [Full Text] [Related]

  • 4. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
    Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker MO, Gattegno B, Richard F, Cussenot O.
    Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
    [Abstract] [Full Text] [Related]

  • 5. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience.
    Daneshmand S, Quek ML, Huffman JL.
    Cancer; 2003 Jul 01; 98(1):55-60. PubMed ID: 12833455
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma.
    Keeley FX, Kulp DA, Bibbo M, McCue PA, Bagley DH.
    J Urol; 1997 Jan 01; 157(1):33-7. PubMed ID: 8976209
    [Abstract] [Full Text] [Related]

  • 7. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract.
    Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML.
    BJU Int; 2008 Nov 01; 102(9):1107-10. PubMed ID: 18522631
    [Abstract] [Full Text] [Related]

  • 8. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD, Sosa RE, Vaughan ED, Scherr DS.
    Urology; 2007 Feb 01; 69(2):251-4. PubMed ID: 17320658
    [Abstract] [Full Text] [Related]

  • 9. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
    Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML.
    Urology; 2008 Apr 01; 71(4):713-7. PubMed ID: 18267338
    [Abstract] [Full Text] [Related]

  • 10. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
    Goel MC, Mahendra V, Roberts JG.
    J Urol; 2003 Mar 01; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
    [Abstract] [Full Text] [Related]

  • 11. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Segura JW, Zincke H, Elliott DS, Blute ML.
    J Urol; 2007 May 01; 177(5):1721-6. PubMed ID: 17437796
    [Abstract] [Full Text] [Related]

  • 12. Imperative indications for conservative management of upper tract transitional cell carcinoma.
    Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Elliott DS, Blute ML.
    J Urol; 2007 Sep 01; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
    [Abstract] [Full Text] [Related]

  • 13. Office-based surveillance ureteroscopy after endoscopic treatment of transitional cell carcinoma: technique and clinical outcome.
    Reisiger K, Hruby G, Clayman RV, Landman J.
    Urology; 2007 Aug 01; 70(2):263-6. PubMed ID: 17826486
    [Abstract] [Full Text] [Related]

  • 14. Retrograde endoscopic laser therapy and ureteroscopic surveillance for transitional cell carcinoma of the upper urinary tract.
    Mugiya S, Ozono S, Nagata M, Otsuka A, Takayama T, Nagae H.
    Int J Urol; 2006 Jan 01; 13(1):1-6. PubMed ID: 16448423
    [Abstract] [Full Text] [Related]

  • 15. 13-year experience with percutaneous management of upper tract transitional cell carcinoma.
    Clark PE, Streem SB, Geisinger MA.
    J Urol; 1999 Mar 01; 161(3):772-5; discussion 775-6. PubMed ID: 10022682
    [Abstract] [Full Text] [Related]

  • 16. Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma.
    Hendin BN, Streem SB, Levin HS, Klein EA, Novick AC.
    J Urol; 1999 Mar 01; 161(3):783-5. PubMed ID: 10022684
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Endoscopic treatment of upper tract transitional cell carcinoma.
    Soderdahl DW, Fabrizio MD, Rahman NU, Jarrett TW, Bagley DH.
    Urol Oncol; 2005 Mar 01; 23(2):114-22. PubMed ID: 15869996
    [Abstract] [Full Text] [Related]

  • 19. [Definitive endourological treatment in urothelial tumors of the upper urinary tract].
    Rodríguez Rodríguez R, Fernández González I, Galbis Sanjuan F, Fernández Fernández E, Escudero Barrilero A, Lovaco Castellanos F.
    Arch Esp Urol; 1995 Nov 01; 48(9):937-43. PubMed ID: 8554399
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
    Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I, Ozen H.
    J Urol; 2006 Jul 01; 176(1):48-52. PubMed ID: 16753365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.